The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting
2014
Patients with chronic kidney disease (CKD) have an increased risk of cardiovascular disease. Previous studies have suggested that patients with CKD have less therapeutic benefit of antiplatelet therapy. However, the relation between renal function and platelet reactivity is still under debate. On-treatment platelet reactivity was determined in parallel by ADP- and AA-induced light transmittance aggregometry (LTA) and the VerifyNow® System (P2Y12 and Aspirin) in 988 patients on dual antiplatelet therapy, undergoing elective coronary stenting. Patients were divided into two groups according to the presence or absence of moderate/severe CKD (GFR
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
35
References
25
Citations
NaN
KQI